# Retinal Structural and Functional Changes in Patients Treated With BRAF/MEK Inhibitors

> **NCT07431489** · NA · COMPLETED · sponsor: **Institute of Oncology Ljubljana** · enrollment: 30 (actual)

## Conditions studied

- Malignant Melanoma
- MEK Inhibitor-Associated Retinopathy

## Interventions

- **OTHER:** Ophthalmologic Retinal Monitoring During BRAF/MEK Inhibitor Therapy

## Key facts

- **NCT ID:** NCT07431489
- **Lead sponsor:** Institute of Oncology Ljubljana
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-01
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07431489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07431489, "Retinal Structural and Functional Changes in Patients Treated With BRAF/MEK Inhibitors". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07431489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*